Clinical Trials on Neisseria Meningitidis Infection in Spain

Total 2595 results

Pfizer

Completed

NeisVac-C Single Prime Study in Infants

Neisseria Meningitidis

Poland, Spain
GlaxoSmithKline

Completed

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain, Germany, Poland
GlaxoSmithKline

Completed

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
M. Carmen Cabellos Minguez
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital Universitario... and other collaborators

Terminated

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

Seizures | Pneumococcal Meningitis

Spain
Pfizer

Terminated

Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

Meningitis, Meningococcal

Spain
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Finland, Germany, Hungary, Spain
Novartis Vaccines
GlaxoSmithKline

Completed

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Meningococcal Meningitis | Meningoccocal Disease

Hungary, Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

Pneumococcal Meningitis

Spain
Pfizer

Completed

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Meningitis, Meningococcal

Poland, Spain, Australia
Novartis Vaccines

Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Meningococcal Disease | Meningococcal Meningitis

Spain, Italy, United Kingdom, Czech Republic
Novartis Vaccines

Completed

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Meningococcal Disease | Meningococcal Meningitis

Spain, Brazil, Hungary, Peru
Fundacion para la Investigacion Biomedica del Hospital...
Instituto de Salud Carlos III

Completed

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) (DRIVE)

HIV Infection | HCV Coinfection

Spain
GlaxoSmithKline

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Meningitis, Meningococcal

Spain, Finland, Estonia, South Africa, Brazil, Mexico, Russian Federation, France, Turkey
Novartis Vaccines
GlaxoSmithKline

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Meningococcal Disease | Meningococcal Meningitis

Belgium, Czechia, Germany, Italy, Spain, United Kingdom
Pfizer

Completed

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Meningitis, Meningococcal

United States, Australia, Spain, Chile, Finland, Denmark, Estonia, Czech Republic, Germany, Lithuania, Poland, Sweden
Fundacion SEIMC-GESIDA
ViiV Healthcare

Completed

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir (FOSTER-C)

HCV Coinfection | Chronic HIV Infection

Spain
Juan Macías
Spanish National Health System

Unknown

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

HIV Infection | HCV Coinfection

Spain
Hospital Mutua de Terrassa
Institut Català de la Salut; Hospital Vall d'Hebron; Public Health Agency of... and other collaborators

Unknown

Tuberculosis In Children Visiting Friends and Relatives

Tuberculosis Infection

Spain
Fundación Pública Andaluza para la gestión de la...
Hospital Son Espases; Hospital Universitario Virgen Macarena; Hospital Son Llatzer and other collaborators

Completed

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa (PiperTazo)

Pseudomonas Aeruginosa Infection

Spain
Anna Cruceta

Completed

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin (BOC-HIV)

HIV Infections | Hepatitis C | COINFECTION

Spain
Emilio Bouza

Completed

CMV Intensive Care Units

CMV Infection

Spain
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III; Spanish Society of Cardiology

Recruiting

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response (ELISPOT-TC)

CMV Infection | Heart Transplant Infection

Spain
Hospital Virgen de la Luz

Terminated

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

Tuberculosis

Spain
Instituto de Investigación Hospital Universitario...
Crazy Science & Business S.L.

Recruiting

Study for the Validation of a New Biomarker to Determine Predisposition to Infections in Patients With Acute Myocardial Infarction.

Infections in Acute Myocardial Infarction Patients

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis

Infectious Endocarditis

Spain
Fundación Teófilo Hernando, Spain

Unknown

Active Monitoring And Determinants of Incidence Infection of COVDI-19

Coronavirus Infection

Spain
Germans Trias i Pujol Hospital
Fondo de Investigacion Sanitaria

Unknown

Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection (HYPDYN)

Latent Tuberculosis Infection

Spain
Germans Trias i Pujol Hospital
CIBERES CRP-TB program

Unknown

Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner (GRANLATHU)

Tuberculosis

Spain
Emilio Bouza
Elena Reigadas Ramirez; Patricia Muñoz García

Unknown

Validation of a Prediction Score for Recurrent C. Difficile Infection: Implementation for Treatment Algorithm Strategies (Clostri_Score)

Clostridium Difficile Infection

Spain
Dr. Luis Fernandez

Unknown

Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.

Helicobacter Pylori Infection

Spain
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC

Completed

Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. (BEFORE)

Clostridium Difficile Infection

Spain
Vitio Medical S.L.
Hospital Universitario de Navarra; NAVARRABIOMED

Completed

Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture (Viture)

COVID-19 | Infectious Disease | Bacteremia | Cellulitis | Respiratory Infection | Tract Infection, Urinary

Spain
Julia Orígüen
Instituto de Salud Carlos III

Recruiting

Oral Vancomycin vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection (PREVAN)

Clostridioides Difficile Infection

Spain
Fundación Pública Andaluza para la Investigación...
Merck Sharp & Dohme LLC

Completed

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA (CY-CMV-2020)

CMV Infection

Spain
Germans Trias i Pujol Hospital
Archivel Farma S.L.

Completed

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Tuberculosis | Latent Tuberculosis Infection

Spain
Fundación Pública Andaluza para la gestión de la...

Unknown

Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients

Serious Infection

Spain
Hospital Universitari de Bellvitge
Cellestis

Completed

QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (OPTIMIST)

Latent Tuberculosis Infection

Spain
Parc de Salut Mar
Universitat Pompeu Fabra

Completed

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes (MARZINC)

Zinc Deficiency | Sars-CoV-2 Infection

Spain
Hospital General Universitario Gregorio Marañon

Terminated

Ethanol in the Prevention of Central Venous Catheter Infections

Catheter Related Infection

Spain
Hospital Universitario Virgen Macarena
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Enrolling by invitation

Clinical Outcomes in Patients With Infection by Resistant Microorganism

Pneumonia | Staphylococcus Aureus | Urinary Tract Infections | Surgical Site Infection | Escherichia Coli | Bloodstream Infection | Acinetobacter Infections | Pseudomonas Aeruginosa | Skin Infection | Klebsiella Pneumonia | Enterococcus Faecium Infection

Spain
Institut d'Investigació Biomèdica de Girona Dr....

Active, not recruiting

Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection (COVFIS2021)

Rehabilitation | COVID-19 Respiratory Infection | Physical Therapists

Spain
Ignacio Zaragoza García
Hospital Universitario 12 de Octubre

Completed

Effectiveness of a Online Training Program With a Clinical Procedure Standardized in Units of Nursing (CPSUN) (CPSUN)

Infection Control | Preventive Measures

Spain
University Hospital Virgen de las Nieves
Instituto de Salud Carlos III

Unknown

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women (9-VPH-MVIH)

HIV Infections | HPV Infection

Spain
Matilde Zaballos

Unknown

Effects on the Qt Interval of COVID-19 Coronavirus Infection (QT-COVID-19)

Coronavirus Infection | Intensive Care Patients

Spain
Hospital San Carlos, Madrid
Merck Sharp & Dohme LLC

Unknown

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. (VENUS)

HPV Infection | HPV Vaccine | Cervix Lesion | Cervix, Dysplasia

Spain
Fundación de Investigación Biomédica - Hospital...

Completed

Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection (R+OCA)

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

Spain
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca

Terminated

Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients

Corona Virus Infection

Spain

Clinical Trials on Neisseria Meningitidis Infection in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations